Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Novo Integrated Sciences, Inc. (NVOS : OTC)
 
 • Company Description   
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.

Number of Employees: 264

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.00 Daily Weekly Monthly
20 Day Moving Average: 6,046 shares
Shares Outstanding: 19.73 (millions)
Market Capitalization: $0.07 (millions)
Beta: 0.73
52 Week High: $0.74
52 Week Low: $0.00
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 312.50% 293.87%
12 Week 32.00% 11.40%
Year To Date -93.64% -94.03%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
11120 NE 2ND STREET SUITE 100
-
BELLEVUE,WA 98004
USA		 ph: 206-617-9797
fax: -		 info@novointegrated.com http://www.novointegrated.com
 
 • General Corporate Information   
Officers
Robert Mattacchione - Chief Executive Officer and Chairman of the Board
Christopher David - Chief Operating Officer; and Director
Vivek Sethi - Principal Financial Officer
Sarfaraz Ali - Director
Alex Flesias - Director

Peer Information
Novo Integrated Sciences, Inc. (CMTI)
Novo Integrated Sciences, Inc. (CMWLQ)
Novo Integrated Sciences, Inc. (AHG.)
Novo Integrated Sciences, Inc. (ROIX)
Novo Integrated Sciences, Inc. (M.DCE)
Novo Integrated Sciences, Inc. (DHSM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-OUTP/HM CRE
Sector: Medical
CUSIP: 67011T300
SIC: 3510
Fiscal Year
Fiscal Year End: August
Last Reported Quarter: 08/01/24
Next Expected EPS Date: 07/18/25
Share - Related Items
Shares Outstanding: 19.73
Most Recent Split Date: 11.00 (0.10:1)
Beta: 0.73
Market Capitalization: $0.07 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/18/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.00
Price/Cash Flow: -
Price / Sales: 0.00
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 141.89%
Sales Growth
vs. Year Ago Period: -6.72%
vs. Previous Quarter: -2.25%
ROE
05/31/25 - -
02/28/25 - -
11/30/24 - -
ROA
05/31/25 - -
02/28/25 - -
11/30/24 - -
Current Ratio
05/31/25 - -
02/28/25 - -
11/30/24 - -
Quick Ratio
05/31/25 - -
02/28/25 - -
11/30/24 - -
Operating Margin
05/31/25 - -
02/28/25 - -
11/30/24 - -
Net Margin
05/31/25 - -
02/28/25 - -
11/30/24 - -
Pre-Tax Margin
05/31/25 - -
02/28/25 - -
11/30/24 - -
Book Value
05/31/25 - -
02/28/25 - -
11/30/24 - -
Inventory Turnover
05/31/25 - -
02/28/25 - -
11/30/24 - -
Debt-to-Equity
05/31/25 - -
02/28/25 - -
11/30/24 - -
Debt-to-Capital
05/31/25 - -
02/28/25 - -
11/30/24 - -
 

Powered by Zacks Investment Research ©